ALung Technologies

company

About

ALung Technologies develops medical gas exchange devices for the treatment of acute and chronic respiratory disorders.

  • 501 - 1000

Details

Last Funding Type
Series A
Last Funding Money Raised
$14M
Industries
Biotechnology,Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 1997
Number Of Employee
501 - 1000
Operating Status
Active

ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed within the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein.

The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$29.80M
ALung Technologies has raised a total of $29.80M in funding over 2 rounds. Their latest funding was raised on Sep 11, 2013 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 11, 2013 Series B $15.80M 1 Detail
Oct 11, 2010 Series A $14M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
ALung Technologies is funded by 1 investors. MAG Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
MAG Ventures Series B